✦ LIBER ✦

A Risk-Benefit Assessment of Alendronate in the Treatment of Involutional Osteoporosis

✍ Scribed by Dr Jean-Pierre Devogelaer

Book ID: 119925025
Publisher: Springer International Publishing AG
Year: 1998
Tongue: English
Weight: 177 KB
Volume: 19
Category: Article
ISSN: 0114-5916
DOI: 10.2165/00002018-199819020-00005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of Treatment with Calcitriol Comb

Effect of Treatment with Calcitriol Combined with Low-Dosage Alendronate in Involutional Osteoporosis

✍ Prof. Ranuccio Nuti, Giuseppe Martini, Silvia Giovani, Roberto Valenti 📂 Article 📅 2000 🏛 Springer International Publishing AG 🌐 English ⚖ 171 KB

Benefit-Risk Assessment of Raloxifene in

Benefit-Risk Assessment of Raloxifene in Postmenopausal Osteoporosis

✍ Dr Ann Cranney, Jonathan D. Adachi 📂 Article 📅 2005 🏛 Springer International Publishing AG 🌐 English ⚖ 113 KB

Alendronate for the Treatment of Osteopo

Alendronate for the Treatment of Osteoporosis in Men

✍ S. Adami; R. Prizzi; F. Colapietro 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 26 KB

Alendronate for the Treatment of Osteopo

Alendronate for the Treatment of Osteoporosis in Men

✍ Orwoll, Eric; Ettinger, Mark; Weiss, Stuart; Miller, Paul; Kendler, David; Graha 📂 Article 📅 2000 🏛 Massachusetts Medical Society 🌐 English ⚖ 100 KB

Isotope retention for assessment of bone

Isotope retention for assessment of bone turnover in involutional osteoporosis

✍ M. Passeri; E. Palummeri; M. C. Baroni; F. Quaini; A. Quintavalla; M. Barbagallo 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 359 KB

RISK-BENEFIT RATIO OF SODIUM FLUORIDE TR

RISK-BENEFIT RATIO OF SODIUM FLUORIDE TREATMENT IN PRIMARY VERTEBRAL OSTEOPOROSIS

✍ Mamelle, N.; Dusan, R.; Martin, J.L.; Prost, A.; Meunier, P.J.; Guillaume, M.; G 📂 Article 📅 1988 🏛 The Lancet 🌐 English ⚖ 733 KB